Atlas Trials

Intracameral Antibiotic Safety Study

Clinical trial NCT02590523 · SUSPENDED

Trial details

NCT number
NCT02590523
Sponsor
Panhandle Eye Group, LLP
Status
SUSPENDED
Phase
Phase 3
Study type
INTERVENTIONAL
Intracameral AntibioticsCataract SurgeryPhacoemulsificationEndophthalmitisVancomycinMoxifloxacin
Start date
2023-01-01
Primary completion
2024-01-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.